Full Text
Estimating the cost-effectiveness of Vortioxetine versus Desvenlafaxine as first line Therapy for mild to moderate Major depressive Disorder in remitted patients

Abstract

Authors

K.R. Keyloun B. Devine

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×